HPQ CEO Discusses Why HPQ Increased Its Stake in Novacium as Commercialization Nears

by Team HPQ

In a recent interview, HPQ CEO Bernard Tourillon explained why HPQ increased its stake in Novacium from 28.4% to 36.8%.

He said management views Novacium’s technologies as nearing a short- and medium-term inflection point, and HPQ wanted to remain well positioned as commercialization progresses, including outside North America where HPQ sees significant global potential.

Tourillon addressed valuation concerns by noting HPQ did not commission a third-party valuation due to cost and timing, but relied on internal work, comparable discussions, and market feedback. He said HPQ believes it secured favorable terms due to its long-standing relationship with Novacium’s founders and sees the implied valuation as conservative relative to the portfolio’s potential.

He also explained the share-exchange structure as a way to align incentives by moving key Novacium shareholders into HPQ ownership, while confirming HPQ’s North American rights are supported by a binding licensing agreement.

By watching the interview, you’ll gain:

  • Why management increased the stake now
  • How HPQ assessed valuation without a third-party report
  • How the structure aligns incentives and reinforces licensing protections

Watch the full interview here:

Want to Learn More?

If this interview piqued your interest and you want to dive deeper into the work we’re doing, make sure to read the related press release here.

Your continued support is vital in driving our mission forward, and we remain dedicated to keeping you informed about our ongoing projects and achievements.

HPQ Silicon is a Quebec-based TSX Venture Exchange Tier 1 Industrial Issuer. With the support of world-class technology partners PyroGenesis Canada and NOVACIUM SAS, the company is developing new green processes crucial to make the critical materials needed to reach net zero emissions.







    close-link







      close-link







        close-link